GPX4 and immunodeficiency disease: To determine if systemic HDL NP treatment reduces GPX4 expression and increases lipid peroxide accumulation in tumor cells in vivo, we established SUDHL4 tumor xenografts (∼100 mm3 in volume) in severe combined immunodeficiency–beige mice.